1. Home
  2. AYTU vs NBY Comparison

AYTU vs NBY Comparison

Compare AYTU & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.21

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.95

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AYTU
NBY
Founded
N/A
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.4M
31.6M
IPO Year
2015
2007

Fundamental Metrics

Financial Performance
Metric
AYTU
NBY
Price
$2.21
$1.95
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$9.33
N/A
AVG Volume (30 Days)
40.3K
608.2K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.42
EPS
N/A
0.76
Revenue
$27,632,080.00
$370,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$43.75
N/A
P/E Ratio
N/A
$2.57
Revenue Growth
277.47
N/A
52 Week Low
$1.65
$0.43
52 Week High
$3.07
$19.95

Technical Indicators

Market Signals
Indicator
AYTU
NBY
Relative Strength Index (RSI) 42.64 57.82
Support Level $2.17 $1.01
Resistance Level $2.30 $2.52
Average True Range (ATR) 0.10 0.26
MACD 0.02 0.11
Stochastic Oscillator 41.94 96.45

Price Performance

Historical Comparison
AYTU
NBY

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: